Medical University of South Carolina
musc.eduTotal trials
848
Active
179
Phase 3
36
Total enrollment
179,506
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 40 of 62 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Daily Vitamin D3 | — | — | — | — | — | 1 | |
| Daily placebo | — | — | — | — | — | 1 | |
| Bolus vitamin D3 | — | — | — | — | — | 1 | |
| Bolus placebo | — | — | — | — | — | 1 | |
| Remimazolam besylate | — | — | — | — | — | 1 | |
| Preoperative midazolam | — | — | — | — | — | 1 | |
| Progesterone supplementation | — | — | — | — | — | 1 | |
| Varenicline Pill | — | — | — | — | — | 1 | |
| Biologic Agents | — | — | — | — | — | 1 | |
| propofol | — | — | — | — | 2 | ||
| IV N-acetylcysteine | — | — | — | — | — | 1 | |
| IV Placebo | — | — | — | — | — | 1 | |
| NAC and taVNS | — | — | — | — | — | 1 | |
| sterile water and inactive taVNS | — | — | — | — | — | 1 | |
| Methadone | — | — | — | — | — | 1 | |
| Methadone Hydrochloride | — | — | — | — | — | 1 | |
| Varenicline | — | — | 8 | ||||
| oxaliplatin | — | — | — | — | — | 3 | |
| bevacizumab | — | — | — | — | — | 3 | |
| paclitaxel | — | — | — | — | — | 2 | |
| sirolimus | — | — | — | — | — | 2 | |
| Carboplatin | — | — | — | — | 2 | ||
| Pembrolizumab | — | — | — | — | 2 | ||
| Rapamycin | — | — | — | — | 2 | ||
| 8mg dexamethasone | — | — | — | — | — | 1 | |
| Formoterol furmarate | — | — | — | — | — | 1 | |
| Hydroxychloroquine | — | — | — | — | — | 1 | |
| Nelfinavir | — | — | — | — | — | 1 | |
| Hydroxychloroquine, Metformin, Sirolimus | — | — | — | — | — | 1 | |
| Hydroxychloroquine, Metformin, Sirolimus, Dasatanib | — | — | — | — | — | 1 | |
| Hydroxychloroquine, Metformin, Sirolimus, Nelfinavir | — | — | — | — | — | 1 | |
| Hydroxychloroquine, Metformin, Sirolimus, Nelfinavir, Dasatinib | — | — | — | — | — | 1 | |
| Fingolimod 0.5 milligram (mg) [Gilenya] | — | — | — | — | — | 1 | |
| oleoylethanolamide | — | — | — | — | — | 1 | |
| 40 IU Intranasal Oxytocin | — | — | — | — | — | 1 | |
| Buprenorphine Patch | — | — | — | — | — | 1 | |
| Simvastatin 40mg | — | — | — | — | — | 1 | |
| Cyclophosphamide | — | — | — | — | — | 1 | |
| Fludarabine | — | — | — | — | — | 1 | |
| CD19-CD34t metabolically programmed CAR transduced T-cells | — | — | — | — | — | 1 |
22 more active programs hidden
Next readouts
- 2022-12-31
- 2026-04-29
- 2026-06-01
- 2026-06-01
- 2026-06-15
- 2026-06-30
- 2026-06-30
- 2026-11-06
- 2026-11-25
- 2026-12
Top conditions
- Stroke43
- Depression30
- Smoking20
- Smoking Cessation20
- Nicotine Dependence20
- Alcohol Use Disorder19
- Prostate Cancer18
- Alcohol Dependence18
Frequently asked questions about Medical University of South Carolina
- How many clinical trials does Medical University of South Carolina have on ClinicalTrials.gov?
- Medical University of South Carolina is listed as the lead sponsor on 848 clinical trials in ClinicalTrials.gov, 179 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Medical University of South Carolina's trials are in Phase 3?
- 36 of Medical University of South Carolina's trials are in Phase 3, spread across 62 active drug programs.
- What therapeutic areas does Medical University of South Carolina focus on?
- Medical University of South Carolina's most-studied conditions on ClinicalTrials.gov are Stroke, Depression, Smoking, Smoking Cessation, Nicotine Dependence.
- When are Medical University of South Carolina's next clinical trial readouts?
- Medical University of South Carolina has 10 upcoming primary-completion readouts tracked here; the soonest is “Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection”, expected around 2022-12-31.